Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

Specimen Handling 62Magnetic Resonance Spectroscopy 44Cyclophosphamide 32Gemcitabine 29Carboplatin 27Biopsy 26pembrolizumab 23Radiotherapy 23Bevacizumab 23Paclitaxel 22venetoclax 21fludarabine 21Nivolumab 21Cisplatin 21Standard of Care 20Drug Therapy 20Capecitabine 20Oxaliplatin 19Radiosurgery 16Blood Specimen Collection 16Azacitidine 16Interviews as Topic 15Dexamethasone 15toripalimab 14cemiplimab 14Docetaxel 14tislelizumab 13Injections 13anlotinib 11Fluorouracil 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × CD3 Complex × 90 days × Clear all
NCT07408258 2026-04-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

OncoC4, Inc.

Phase 1 Not yet recruiting
20 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡